Rifampicin and treatment of cholestatic pruritus.
Hofmann
A F
AF
D000499:Allylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001647:Bile Acids and Salts / Q000378:metabolism*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000150:complications / Q000378:metabolism*; D000069472:Colesevelam Hydrochloride; D006801:Humans; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D012293:Rifampin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D000499:Allylamine; D000069472:Colesevelam Hydrochloride; D012293:Rifampin